Annual Drug Patent Expirations for NEXAVAR Nexavar is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Bayer Hlthcare drug NEXAVAR appeared firs…
New patent expiration for Bayer Hlthcare drug NEXAVAR Read Post »
NEXAVAR (sorafenib tosylate) Bayer hlthcare Patent: 8,618,141 Expiration: Feb 11, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dru…
Drug Patent Expirations for the Week of February 5, 2023 Read Post »
NEXAVAR (sorafenib tosylate) Bayer hlthcare Patent: 8,618,141 Expiration: Feb 11, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dru…
Drug Patent Expirations for the Week of February 5, 2023 Read Post »
Annual Drug Patent Expirations for OPANA+ER Opana Er is a drug marketed by Endo Pharms and is included in two NDAs. There are eleven patents protecting this drug and six…
The post New patent expiration for Endo Pharms drug OPANA ER appeared first on Dr…
New patent expiration for Endo Pharms drug OPANA ER Read Post »
Annual Drug Patent Expirations for CHANTIX Chantix is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from three suppliers. There are two…
The post New patent expiration for Pf Prism drug CHANTIX appeared first on DrugPatentW…
Annual Drug Patent Expirations for KYNMOBI Kynmobi is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are nineteen…
The post New patent expiration for Sunovion Pharms drug KYNMOBI appeared fir…
New patent expiration for Sunovion Pharms drug KYNMOBI Read Post »
Annual Drug Patent Expirations for ZYKADIA Zykadia is a drug marketed by Novartis and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent expiration for Novartis drug ZYKADIA appeared fir…
Annual Drug Patent Expirations for NOURIANZ Nourianz is a drug marketed by Kyowa Kirin and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Kyowa Kirin drug NOURIANZ appeared first on…
New patent expiration for Kyowa Kirin drug NOURIANZ Read Post »
JANUMET XR (metformin hydrochloride; sitagliptin phosphate) Merck sharp dohme Patent: 6,699,871 Expiration: Jan 26, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Drug Patent Expirations…
Drug Patent Expirations for the Week of January 22, 2023 Read Post »
Annual Drug Patent Expirations for STEGLUJAN Steglujan is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Msd Sub drug STEGLUJAN appeared first on DrugPa…
New patent expiration for Msd Sub drug STEGLUJAN Read Post »